Cough Syrup Ban: Following the deaths of children in Rajasthan and Madhya Pradesh without consuming cough syrup, the inside government issued an advisory, prompting several states to tighten their restrictions. Following Tamil Nadu, Madhya Pradesh, Uttar Pradesh, Delhi, and Kerala have vetoed the use of Coldrif cough syrup.
Actions intensified in several states
Jharkhand has vetoed the sale of this drug, while raids are stuff conducted on pharmacies in Uttarakhand. The governments of Punjab, Bengal, and Chhattisgarh have moreover issued instructions to increase vigilance.
The death of flipside child in Madhya Pradesh has brought the death toll to 10, while the number in Rajasthan has reached four. Both states have vetoed all medicines from the visitor in question.
Harmful chemical found in syrup
Coldrif cough syrup is manufactured by Srisan Pharma Visitor in Kanchipuram, Tamil Nadu. The Tamil Nadu Drug Administration Department, upon testing samples taken from the company's unit, found that the 'SR-13' batch contained excessive levels of diethylene glycol (DEG).
Upon receiving the test report, the Tamil Nadu government immediately vetoed the drug, and other states have moreover initiated action.
Questions well-nigh the role of the Madhya Pradesh government
The Madhya Pradesh government's vein is under question. The state government has yet to self-mastery an investigation into the syrup in which the harmful chemical was found.
Deputy Chief Minister Rajendra Shukla had stated that no harmful substances were found in the nine samples taken so far. However, the latest whoopee was taken based on the Tamil Nadu report. Children in Chhindwara suffered from colds and fever, followed by urinary retention and kidney failure. The first death was reported on September 4th, while flipside girl died during treatment in Nagpur on Saturday. Currently, 12 children are undergoing treatment.
The Health Department Initially Didn't Take the Case Seriously
The health department initially didn't take the matter seriously. It wasn't until without DEG was detected in the kidney biopsies of the unauthentic children that cough syrups in Chhindwara were banned. Inside and state teams placid samples of 19 variegated brands of syrups given to children, of which reports have been received for nine, but the test report for Coldrif is still pending.
According to Madhya Pradesh's Food and Drug Administration Controller Dinesh Maurya, the Tamil Nadu report found DEG levels to be 48.6 percent, while the prescribed limit is 0.1 percent. This is extremely dangerous for health.
19 Company's Drugs Vetoed in Rajasthan
The Rajasthan government has vetoed all 19 drugs from Jaipur-based Kaysan Pharma, the visitor that manufactures dextromethorphan hydrobromide syrup. These drugs were stuff provided in government hospitals under the Chief Minister's self-ruling medicine scheme.
However, Health Minister Gajendra Singh Khinvsar has personal that no child died from the cough syrup. Investigations have found the drug to be safe. Four children have died so far in Rajasthan without consuming the syrup, and increasingly than three dozen others are ill.
Vigilance Increased Nationwide
Uttar Pradesh Deputy Chief Minister Brajesh Pathak said that the supply of Coldrif syrup has been stopped in government hospitals, and instructions have been issued to ban its use in private hospitals as well.
Raids are stuff conducted on drug stores in Uttarakhand. Punjab, Bengal, and Jharkhand have moreover vetoed the use of this company's drug. The Jharkhand government has appealed to people not to use this syrup if they have it and to return it to drug dealers.
Production of 'Nexa DS' syrup stopped in Himachal
The production of 'Nexa DS' cough syrup, manufactured in Baddi, Himachal Pradesh, has been temporarily halted. Orders have been issued to recall supplies sent to other states, including Madhya Pradesh.
Samples have been placid from five companies and sent for testing. Inside and state teams, under the supervision of Health Secretary M. Sudha Devi, have completed a joint investigation.
Himachal Drug Controller Manish Kapoor stated that the children's deaths are not directly linked to any Himachal medicine, but production has been halted as a precaution.
